XML 53 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Licensed rights and other intangible assets - Summary of Information about License Rights and Other Intangible Assets, Net (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount $ 48,097 $ 47,854
Finite-Lived Intangible Assets, Accumulated Amortization 9,696 7,868
Finite-Lived Intangible Assets, Net 38,401 39,986
License Rights and Intangible Assets, Net, Gross Carrying Amount (Excluding Goodwill) 48,417 48,186
License rights and other intangible assets, net 38,721 40,318
License rights [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount 40,000 40,000
Finite-Lived Intangible Assets, Accumulated Amortization 8,333 6,826
Finite-Lived Intangible Assets, Net 31,667 33,174
Hormone therapy drug patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount 6,161 5,834
Finite-Lived Intangible Assets, Accumulated Amortization 1,363 1,042
Finite-Lived Intangible Assets, Net 4,798 4,792
Hormone therapy drug candidate patents - applied and pending [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount 1,936 2,020
Finite-Lived Intangible Assets, Net 1,936 2,020
Trademarks/trade name rights [Member]    
Finite-Lived Intangible Assets [Line Items]    
Indefinite-Lived Intangible Assets, Gross Carrying Amount and Net $ 320 $ 332